1. Introduction – Paracetamol Tablets IP 650 mg:
Paracetamol Tablets IP 650 mg are widely used pharmaceutical formulations containing 650 mg of Paracetamol, an analgesic and antipyretic agent commonly prescribed for the relief of mild to moderate pain and reduction of fever. The product is manufactured in accordance with applicable Indian Pharmacopoeia (IP) specifications to ensure consistent quality, safety, and efficacy. The Batch Packing Record (BPR) of Paracetamol Tablets IP 650 mg is an essential Good Manufacturing Practice (GMP) document that provides comprehensive details of packaging operations, material dispensing, equipment preparation, line clearance, in-process quality checks, and finished product reconciliation. The packing process includes blister packaging, overprinting verification, carton packing, shipper packing, and final product identification. The specified pack configuration is 10 × 5 × 10 blister, ensuring systematic packaging and distribution. Critical packaging parameters, including sealing temperature, machine speed, leak testing, environmental conditions, and packaging integrity, are monitored and documented throughout operations. The BPR also covers packaging material reconciliation, rejection analysis, destruction records, yield calculations, and Quality Assurance verification. Proper documentation ensures batch traceability, minimizes packaging errors, prevents product mix-ups, and supports regulatory compliance. The completed BPR provides documented evidence that packaging activities were performed according to approved procedures and established pharmaceutical quality standards.
Skip to PDF content2. Flow Diagram – Batch Packing Process of Paracetamol Tablets IP 650 mg:
The flow diagram illustrates the systematic batch packing process of Paracetamol Tablets IP 650 mg, ensuring product quality, packaging integrity, traceability, and compliance with Good Manufacturing Practices (GMP).
The process begins with the receipt and verification of approved bulk tablets transferred from the manufacturing department to the packing section. Following equipment cleaning and line clearance, tablets undergo visual inspection before primary packaging in blister packs.During blister packing, critical parameters such as sealing temperature, machine speed, leak testing, and blister appearance are monitored. The packed blisters proceed to secondary packaging, where they are placed into cartons according to the approved pack configuration. Subsequently, cartons are packed into shippers, and printed information, including batch number, manufacturing date, and expiry date, is verified. Finally, packaging material reconciliation, rejection analysis, and yield calculations are completed. Finished products undergo Quality Assurance review and release before transfer to the finished goods storage area.
3. Critical Process Parameters (CPP) and Critical Quality Attributes (CQA) of Paracetamol Tablets IP 650 mg – Packing Process:
Critical Process Parameters (CPP) and Critical Quality Attributes (CQA) are essential for ensuring the consistent quality, safety, and integrity of Paracetamol Tablets IP 650 mg during packaging operations.
Critical Process Parameters (CPP) include blister forming temperature, sealing temperature, machine speed, tablet feeding, overprinting accuracy, and carton packing settings. These parameters require appropriate monitoring and control to prevent packaging defects, improper sealing, tablet damage, and labeling errors.
Critical Quality Attributes (CQA) include blister integrity, leak-test compliance, correct tablet count, legible printing, accurate batch details, carton integrity, and shipper packaging quality. These attributes ensure that the finished product meets approved packaging specifications and regulatory requirements. Routine in-process checks, equipment verification, packaging material reconciliation, and rejection analysis help maintain process consistency and minimize quality risks. Effective monitoring and documentation of CPPs and CQAs support Good Manufacturing Practices (GMP), batch traceability, product protection, and Quality Assurance review before finished product release.